Sagamihara, Japan

Masataka Kuroki


Average Co-Inventor Count = 2.6

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Sagamihara, JA (1977)
  • Sagamihara, JP (1979 - 1980)

Company Filing History:


Years Active: 1977-1980

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Masataka Kuroki: Innovator in Amidoxime Derivatives

Introduction

Masataka Kuroki is a notable inventor based in Sagamihara, Japan. He has made significant contributions to the field of chemistry, particularly in the development of novel amidoxime derivatives. With a total of three patents to his name, Kuroki's work has implications for the pharmaceutical industry.

Latest Patents

Kuroki's latest patents focus on novel amidoxime derivatives that are useful as raw materials for 3-amino-5-methyl isoxazole. These derivatives are characterized by specific structural formulas, where R₁ can represent a methyl or ethyl group, and R₂ can represent hydrogen or a methyl group. The preparation of these derivatives from β-amino crotonitrile allows for the production of isoxazole without generating any by-products of isomer. This innovation is particularly valuable as isoxazole serves as an intermediate for various medicines.

Career Highlights

Masataka Kuroki is currently employed at Sogo Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has not only contributed to the scientific community but has also enhanced the capabilities of his company in the pharmaceutical sector.

Collaborations

Kuroki has collaborated with notable coworkers, including Sadamitsu Kono and Kazuyuki Shioka. Their combined expertise has fostered a productive environment for innovation and development in their field.

Conclusion

Masataka Kuroki's contributions to the field of amidoxime derivatives highlight his role as a significant inventor in the pharmaceutical industry. His innovative work continues to pave the way for advancements in medicine and chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…